Solutions
Neurosurgeon operating with intraoperative brain imaging
Neurosurgery
Functional brain-network data for complex neurosurgical decisions.
Clinician reviewing brain imaging on a monitor
Neurology
Objective brain function insights for more informed neurological care.
Older couple walking outdoors
Brain Health
Supporting healthier brains through earlier insight.
Clinicians reviewing a brain scan on a monitor
Clinical Research
Empowering the next generation of neuroscience research.
TechnologyResourcesQuantalX NeuroscienceReimbursementAboutContact us
QuantalX Neuroscience
All resources
Peer-reviewed publication
Parkinsonism & Related Disorders
2021

A multimodal approach using TMS and EEG reveals neurophysiological changes in Parkinson's disease

Maidan I, Zifman N, Hausdorff JM, Giladi N, Levy-Lamdan O, Mirelman A

Parkinsonism journal cover
Key finding

Patients with Parkinson's disease showed lower early phase deflection, lower inter-trial adherence and lower connectivity between homologous areas than healthy controls.

Study design
Case-control study, TMS-EEG
Participants
32 patients with Parkinson's disease and 21 healthy controls

Summary

This study examined how the brain responds to targeted magnetic stimulation in Parkinson's disease (PD). Combined transcranial magnetic stimulation and electroencephalography (TMS-EEG) was used to compare the electrical responses of patients with PD and healthy controls to stimulation of four cortical areas.

Study design

  • Participants: 32 patients with PD and 21 healthy controls.
  • Stimulation sites: left and right primary motor cortex (M1) and left and right dorsolateral prefrontal cortex (DLPFC).
  • Six measures of the TMS-evoked potential (TEP): waveform adherence, late phase deflection, early phase deflection, short-term plasticity, inter-trial adherence, and connectivity between right and left M1 and DLPFC.
  • Analysis: linear mixed model comparing groups and stimulated areas.

Key findings

  • Compared with healthy controls, patients with PD showed lower early phase deflection (p = 0.009), lower inter-trial adherence (p < 0.001) and lower connectivity between homologous areas (p = 0.050). Waveform adherence showed a trend in the same direction (p = 0.052).
  • Late phase deflection and short-term plasticity did not differ between the groups.
  • Lower inter-trial adherence correlated with longer disease duration (r = −0.355, p = 0.050).

Authors' conclusions

The authors report several alterations in neurophysiological measures in patients with PD. They suggest that higher cortical excitability, greater variability and less widespread evoked potentials may help explain different aspects of the pathophysiology of the disease.

Read the full article

Maidan I, Zifman N, Hausdorff JM, Giladi N, Levy-Lamdan O, Mirelman A. A multimodal approach using TMS and EEG reveals neurophysiological changes in Parkinson's disease. Parkinsonism & Related Disorders. 2021;89:28–33. doi:10.1016/j.parkreldis.2021.06.018

Summary prepared by QuantalX from the published abstract. All results are as reported by the authors. The full text is available from the publisher.

Bring brain function data into your practice

Talk to the QuantalX team about Delphi-MD™ in your clinical setting.

Request a demo
On this page
Section
Journal
Parkinsonism & Related Disorders
Year
2021
DOI
10.1016/j.parkreldis.2021.06.018
Licence
Copyright Elsevier. Summary by QuantalX
Read in the journal
QuantalX Neuroscience
Join our newsletter to stay up to date on clinical updates and company news.
By subscribing you agree to our Privacy Policy and provide consent to receive updates from our company.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Solutions
NeurosurgeryNeurologyBrain HealthClinical ResearchPsychiatry
Company
TechnologyPartner ZoneResourcesAbout UsContact
Follow us
Facebook
Instagram
X
LinkedIn
© 2026 Quantalx. All rights reserved.
Privacy PolicyTerms of Service
*All clinical interpretations of Delphi-MD™ assessments must be made by qualified healthcare professionals within the context of a full patient evaluation. The Delphi-MD™ system is intended to elicit, record, and analyze TMS-evoked brain potentials (TEPs) and provide quantitative output parameters compared against a normative reference database limited to ages 50–75. Adverse events during or after evaluation may include headache, nausea, dizziness, fatigue, insomnia, anxiety/agitation, back or neck pain, vomiting, tinnitus, migraine aura, and abnormal sensations. Delphi-MD™ is not intended to be relied upon solely to make or confirm a diagnosis. For more information, refer to the Delphi-MD™ user manual.
Schedule a Demo